Research output per year
Research output per year
Fingerprint
Dive into the research topics where Christopher Ryan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A phase 4, multicenter, global clinical study to evaluate discontinuation and rechallenge of pexidartinib in patients with tenosynovial giant cell tumor previously treated with pexidartinib
Desai, J., Wagner, A. J., Carrasco Garcia, I., Cesari, M., Gordon, M., Lin, C. C., Papai, Z., Ryan, C. W., Tap, W. D., Trent, J. C., Gelderblom, H., Grimison, P., López Pousa, A., Van Tine, B. A., Rubinacci, M., Dai, D., Rajper, A. W., Tecson, K., Wooddell, M. & Stacchiotti, S., Jan 1 2025, In: Cancer. 131, 1, e35634.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors SWOG S1609: Vulvar Cancers
Chae, Y. K., Corthell, L., Patel, S. P., Edwards, R., Scalici, J. M., Kim, H. S., Chung, L. I. Y., Othus, M., McLeod, C. M., Chen, H. X., Sharon, E., Streicher, H., Ryan, C. W., Blanke, C. D. & Kurzrock, R., Jan 15 2025, In: Clinical Cancer Research. 31, 2, p. 308-315 8 p.Research output: Contribution to journal › Article › peer-review
-
Dual anti-CTLA-4 and anti-PD-1 blockade in metastatic basal cell carcinoma
Patel, S. P., Cano-Linson, E., Chae, Y. K., Schokrpur, S., Lao, C. D., Powers, B. C., Victor, A. I., Onitilo, A. A., Shin, S., Takebe, N., Threlkel, S., McLeod, C. M., Chen, H. X., Sharon, E., Othus, M., Ryan, C. W., Blanke, C. D. & Kurzrock, R., Dec 2025, In: npj Precision Oncology. 9, 1, 24.Research output: Contribution to journal › Article › peer-review
Open Access -
Adjuvant everolimus after renal cell carcinoma nephrectomy – Authors' reply
Ryan, C. W., Tangen, C. M. & Lara, P. N., Nov 9 2024, In: The Lancet. 404, 10465, p. 1810 1 p.Research output: Contribution to journal › Letter › peer-review
-
Adjuvant Everolimus in Non-Clear Cell Renal Cell Carcinoma A Secondary Analysis of a Randomized Clinical Trial
Gulati, S., Tangen, C., Ryan, C. W., Vaishampayan, U. N., Shuch, B. M., Barata, P. C., Pruthi, D. K., Bergerot, C. D., Tripathi, A., Lerner, S. P., Thompson, I. M., Lara, P. N. & Pal, S. K., Aug 6 2024, In: JAMA Network Open. 7, 8, e2425288.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations